Program
Break
CME Session
EAS Stage
Industry session
Joint Session
Late Breaker
Parallel session
Plenary
SaaG Session (E-Poster Screens)
Workshop
Break
CME Session
EAS Stage
Industry session
Joint Session
Late Breaker
Parallel session
Plenary
SaaG Session (E-Poster Screens)
Workshop
| Time | Anitschkow Hall | William Harvey Hall | Exhibition | Hall 1 | Foyer |
|---|---|---|---|---|---|
| 13:30-14:45 |
CME Session: Intensive and Early Ldl-C Treatment: for Whom?
|
||||
| 14:45-15:00 |
Coffee Break
|
||||
| 15:00-16:15 |
Industry Sponsored Educational Symposium 01 (Not CME-accredited session)
|
||||
| 16:30-17:45 |
CME Session: Pre/Event Management of LDL-C: getting the right patient at the right time
|
||||
| 17:45-18:00 |
Break
|
||||
| 18:00-18:45 |
Opening Ceremony
|
||||
| 18:45-19:35 |
The Anitschkow Lecture
|
||||
| 19:35-21:20 |
Welcome Reception
|
| Time | Anitschkow Hall | William Harvey Hall | Michael Davies Hall | James Black Hall | Exhibition | EAS Stage in the Exhibition | Station 01 | Station 02 | Station 03 | Station 04 | Station 05 | Station 06 | Station 07 | Station 08 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 08:30-10:30 |
Plenary 1: Sex and gender in cardiovascular disease
|
|||||||||||||
| 10:30-11:00 |
Coffee break, Exhibition & Poster viewing
|
EAS stage: Outreach - Lp(a) International Task Force
|
||||||||||||
| 11:00-12:30 |
NLA/EAS joint session: Early, Sustained, and Comprehensive Control of Lipids and Health: From Therapies to Models of Care
|
|||||||||||||
| 12:30-14:00 |
EAS stage: Case presentations and discussions
|
|||||||||||||
| 12:45-13:15 |
Keynote Lecture
|
|||||||||||||
| 13:30-14:45 |
CME Session: High Lp(a): why does it matter?
|
Industry Sponsored Educational Symposium 02 (Not CME-accredited session)
|
||||||||||||
| 13:30-14:30 |
CME Session: Combination Therapy for LDL-C: Pathways to Goal Attainment
|
SaaG Session: The Endothelium as Gatekeeper in CVD
|
SaaG Session: Lipid Metabolism: Novel Regulators, Therapeutics and Mechanisms
|
SaaG Session: Population Trends and Management Strategies in Cardiovascular Risk
|
SaaG Session: Lipid Lowering Therapies and Advances in Vascular Therapeutics
|
SaaG Session: FH and Inherited Dyslipidemias: Clinical Perspectives
|
SaaG Session: Diabetes: Cardiovascular Connections and Clinical Implications
|
SaaG Session: Emerging Lipid-Lowering Strategies: Mechanisms, Pre-clinical Studies and Outcomes
|
SaaG Session: AI and Advanced Analytics in Cardiovascular Research
|
|||||
| 14:00-15:00 |
EAS stage: EAS behind the scene
|
|||||||||||||
| 14:35-15:35 |
SaaG Session: Arterial Wall Biology: From Molecular Mechanisms to Plaque Stability
|
SaaG Session: Inflammation in CVD: T Cells, Macrophages, and Beyond
|
SaaG Session: Lipoprotein Dynamics: HDL to Remnants
|
SaaG Session: Molecular Mechanisms and Biomarkers in Aortic Valve Stenosis
|
SaaG Session: Genetic insights in FH and Dyslipidemia
|
SaaG Session: Adipose Tissue: Molecular Insights and Cardiovascular Implications
|
SaaG Session: Next-Generation Lipid-Lowering: PCSK9 Inhibitors and Other Novel Targets
|
|||||||
| 15:00-15:45 |
EAS stage: EAS research grant winners
|
|||||||||||||
| 15:30-15:45 |
Coffee break, Exhibition & Poster viewing
|
|||||||||||||
| 15:45-17:15 |
ASPC/EAS Joint session: Triglycerides: From Pathophysiology to Clinical Practice
|
Late Breaker Session: Basic & Translational Late Breaking Science
|
||||||||||||
| 17:20-17:50 |
Debate session: Is LDL lowering a solved problem?
|
|||||||||||||
| 17:20-18:50 |
Poster Networking
|
|||||||||||||
| 17:30-18:15 |
EAS stage: EAS research grant winners
|
| Time | Anitschkow Hall | William Harvey Hall | Michael Davies Hall | James Black Hall | Exhibition | EAS Stage in the Exhibition | Station 01 | Station 02 | Station 03 | Station 04 | Station 05 | Station 06 | Station 07 | Station 08 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 08:30-10:30 |
Plenary 2: Non-traditional risk factors for atherosclerosis
|
|||||||||||||
| 10:30-11:00 |
Coffee break, Exhibition & Poster viewing
|
|||||||||||||
| 11:00-12:30 |
ESC/EAS joint symposium: New Horizons in the Understanding of the Inflammatory Nature of Atherosclerosis
|
|||||||||||||
| 12:30-14:00 |
EAS stage: Case presentation and discussion
|
|||||||||||||
| 12:45-13:15 |
Hugh Sinclair lecture
|
|||||||||||||
| 13:30-14:30 |
Special EAS session: Global Highlights
|
SaaG Session: The Multiple Faces of Smooth Muscle Cells
|
SaaG Session: Frontiers in Lipid Metabolism
|
SaaG Session: Novel Biomarkers and Molecular Mechanisms in CVD
|
SaaG Session: FH and Hypercholesterolemia: Emerging Therapies and Clinical Insights
|
SaaG Session: Immune Cell Dynamics in CVD: Monocytes, T Cells, Neutrophils and Macrophages
|
SaaG Session: Neurological Disorders and Cardiovascular Interplay: Epigenetic and Metabolism
|
SaaG Session: Real-World Effectiveness in Lipid Management
|
SaaG Session: Emerging Therapies and Genetic Insights in Cardiovascular Risk Management
|
|||||
| 13:30-14:15 |
Industry Sponsored Special lecture 03 (Not CME-accredited session)
|
|||||||||||||
| 14:00-15:30 |
EAS stage: EAS behind the scene
|
|||||||||||||
| 14:35-15:35 |
SaaG Session: Plaque Biology: Molecular Insights and Cellular Dynamics
|
SaaG Session: The importance of Lp(a)
|
SaaG Session: Cardiac Injury: Mechanisms and Detection
|
SaaG Session: Diabetes: Metabolic Signatures Unveiled
|
SaaG Session: Liver Pathophysiology: Metabolic Disorders and Cardiovascular Risk
|
SaaG Session: Integrative Approaches to Lipid Control and Cardiovascular Risk
|
SaaG Session: Epidemiology: From Prevention to Prognosis
|
|||||||
| 14:45-15:30 |
Industry Sponsored Special lecture 04 (Not CME-accredited session)
|
Industry Sponsored Special lecture 05 (Not CME-accredited session)
|
||||||||||||
| 15:30-15:45 |
Coffee break, Exhibition & Poster viewing
|
|||||||||||||
| 15:45-17:15 |
IAS/EAS Joint session: FH – Current status worldwide and how can implementation science help us improve
|
|||||||||||||
| 17:20-18:50 |
Poster Networking
|
|||||||||||||
| 17:30-18:30 |
General Assembly (EAS members only)
|
| Time | Anitschkow Hall | William Harvey Hall | Exhibition |
|---|---|---|---|
| 08:30-10:30 |
Plenary 3: Artificial intellegence and atherosclerosis: A glimpse into the future
|
||
| 10:30-11:00 |
Coffee break, Exhibition & Poster viewing
|
||
| 11:00-12:30 |
Late Breaker Session: Clinical
|